<DOC>
	<DOCNO>NCT01043666</DOCNO>
	<brief_summary>This study ass efficacy safety YM178 patient symptoms overactive bladder .</brief_summary>
	<brief_title>A Study YM178 Subjects With Symptoms Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<mesh_term>Mirabegron</mesh_term>
	<criteria>Subjects symptoms overactive bladder least 12 week study Subjects capable walk lavatory without assistance measure urine volume him/herself Subject average frequency micturition 8 time per 24hour period Subject average episode urgency urge incontinence one time per 24hours period Subject provide write informed consent him/herself Subject stress urinary incontinence predominant symptom Subject transient symptom suspect overactive bladder Subject complicate urinary tract infection , urinary stone , and/or interstitial cystitis historical condition recurrent urinary tract infection Subject complicate bladder tumor/prostatic tumor historical condition Subject confirm postvoid residual volume &gt; =100ml clinically significant low urinary tract obstructive disease Subject indwelling catheter practice intermittent selfcatheterization Subject give radiotherapy influence urinary tract function , thermotherapy benign prostatic hyperplasia Subject give surgical therapy may influence urinary tract function within 24 week study Subject uncontrolled hypertension ( indicated sit SBP &gt; =180mmHg DPB &gt; = 110mmHg ) Subject pulse rate &gt; = 110bpm &lt; 50 bpm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Micturition</keyword>
	<keyword>YM178</keyword>
	<keyword>Urinary incontinence</keyword>
	<keyword>Frequency</keyword>
	<keyword>Overactive Bladder</keyword>
	<keyword>Urgency</keyword>
	<keyword>Urinary urge incontinence</keyword>
</DOC>